Meghan Fitzgerald
Director · 8 filings · Latest: Sep 16, 2026
Roivant Sciences Ltd.
TENET HEALTHCARE CORP
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ROIV | Meghan Fitzgerald | Director | Sep 15, 2026 | Sale | $39.74 | 5,112 | $203.2K | 36,108 | |
ROIV | MEGHAN FITZGERALD | — | Sep 15, 2026 | Proposed Sale | $41.02 | 5,112 | $209.7K | — | |
ROIV | Meghan Fitzgerald | Director | Sep 8, 2026 | Sale | $39.90 | 20,000 | $798.0K | 42,963 | |
ROIV | Meghan Fitzgerald | Director | Sep 8, 2026 | Option Exercise | $8.80 | 20,000 | $176.0K | 62,963 | |
ROIV | MEGHAN FITZGERALD | — | Sep 8, 2026 | Proposed Sale | $34.93 | 20,000 | $698.6K | — | |
ROIV | Meghan Fitzgerald | Director | Jun 30, 2026 | Sale | $34.90 | 10,000 | $349.0K | 42,963 | |
ROIV | Meghan Fitzgerald | Director | Jun 30, 2026 | Option Exercise | $8.80 | 10,000 | $88.0K | 52,963 | |
ROIV | MEGHAN FITZGERALD | — | Jun 30, 2026 | Proposed Sale | $34.73 | 10,000 | $347.3K | — | |
THC | Meghan Fitzgerald | Director | May 22, 2026 | Option Exercise | — | 1,333 | — | 17,580 | |
ROIV | Meghan Fitzgerald | Director | Mar 26, 2026 | Sale | $27.45 | 70,000 | $1.9M | 42,963 | |
ROIV | Meghan Fitzgerald | Director | Mar 26, 2026 | Option Exercise | $8.80 | 70,000 | $616.0K | 112,963 | |
ROIV | MEGHAN FITZGERALD | — | Mar 26, 2026 | Proposed Sale | $27.45 | 70,000 | $1.9M | — |